Ratings by Citizens (Silvan Turkcan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/22/2026 | Prime Medicine | PRME | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/16/2026 | TuHURA Biosciences | HURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/15/2026 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/10/2026 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/9/2026 | Ideaya Biosciences | IDYA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/3/2026 | Celcuity Inc | CELC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/2/2026 | Ideaya Biosciences | IDYA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/28/2026 | Celcuity Inc | CELC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/20/2026 | Relay Therapeutics | RLAY | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/18/2026 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/18/2026 | Celcuity Inc | CELC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/18/2026 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/8/2026 | Engene Holdings Inc. | ENGN | Downgrade | Market Perform (Market Outperform) |
8.85 (1.71) |
-80.68% | Details | |
| 5/5/2026 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/4/2026 | Celcuity Inc | CELC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/28/2026 | Relay Therapeutics | RLAY | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/28/2026 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/27/2026 | TuHURA Biosciences | HURA | New Coverage | Market Outperform (N/A) |
2.29 (2.64) |
15.28% | Details | |
| 4/27/2026 | Celcuity Inc | CELC | New Coverage | Market Outperform (N/A) |
113.56 (90.21) |
-20.56% | Details | |
| 4/1/2026 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/25/2026 | Context Therapeutics | CNTX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/23/2026 | Ideaya Biosciences | IDYA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/17/2026 | Relay Therapeutics | RLAY | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/16/2026 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/12/2026 | Engene Holdings Inc. | ENGN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/4/2026 | Prime Medicine | PRME | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2026 | Relay Therapeutics | RLAY | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2026 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2026 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/25/2026 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/24/2026 | MacroGenics | MGNX | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 2/11/2026 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/10/2026 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/6/2026 | Ideaya Biosciences | IDYA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/9/2026 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/5/2026 | Engene Holdings Inc. | ENGN | Maintain | Market Outperform (Market Outperform) |
|
Details |
